SIGA · SIGA Technologies
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
31 East 62nd Street, New York, NY, 10065, United States
Drug Manufacturers - Specialty & Generic
Healthcare
Market Cap
212M
52 Wk Range
$2.83 - $8.46
Previous Close
$2.95
Open
$2.98
Volume
720,714
Day Range
$2.96 - $3.14
Enterprise Value
95.53M
Cash
117.6M
Avg Qtr Burn
N/A
Insider Ownership
42.73%
Institutional Own.
49.72%
Qtr Updated
Jun 30th 2026